Secondaries announced 12/7/2016
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Clearside Biomedical, Inc. Symbol: CLSD Price: Last trade $14.43 Trade Date: 12/9 Shares: 5.2 million Underwriter(s)J.P. Morgan, Cowen, Stifel CoManager(s)Wedbush PacGrow[…]